187 related articles for article (PubMed ID: 14656478)
1. AMH signaling: from receptor to target gene.
Visser JA
Mol Cell Endocrinol; 2003 Dec; 211(1-2):65-73. PubMed ID: 14656478
[TBL] [Abstract][Full Text] [Related]
2. Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.
Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
Mol Cell Endocrinol; 2003 Dec; 211(1-2):15-9. PubMed ID: 14656471
[TBL] [Abstract][Full Text] [Related]
3. Components of the anti-Müllerian hormone signaling pathway in gonads.
di Clemente N; Josso N; Gouédard L; Belville C
Mol Cell Endocrinol; 2003 Dec; 211(1-2):9-14. PubMed ID: 14656470
[TBL] [Abstract][Full Text] [Related]
4. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
[TBL] [Abstract][Full Text] [Related]
5. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
6. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.
Gouédard L; Chen YG; Thevenet L; Racine C; Borie S; Lamarre I; Josso N; Massague J; di Clemente N
J Biol Chem; 2000 Sep; 275(36):27973-8. PubMed ID: 10854429
[TBL] [Abstract][Full Text] [Related]
7. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
[TBL] [Abstract][Full Text] [Related]
8. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone and its receptors.
Josso N; di Clemente N; Gouédard L
Mol Cell Endocrinol; 2001 Jun; 179(1-2):25-32. PubMed ID: 11420127
[TBL] [Abstract][Full Text] [Related]
10. AMH and AMH receptor defects in persistent Müllerian duct syndrome.
Josso N; Belville C; di Clemente N; Picard JY
Hum Reprod Update; 2005; 11(4):351-6. PubMed ID: 15878900
[TBL] [Abstract][Full Text] [Related]
11. Requirement of Bmpr1a for Müllerian duct regression during male sexual development.
Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
Nat Genet; 2002 Nov; 32(3):408-10. PubMed ID: 12368913
[TBL] [Abstract][Full Text] [Related]
12. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
[TBL] [Abstract][Full Text] [Related]
13. Anti-Müllerian hormone, beta-catenin and Müllerian duct regression.
Xavier F; Allard S
Mol Cell Endocrinol; 2003 Dec; 211(1-2):115-21. PubMed ID: 14656484
[TBL] [Abstract][Full Text] [Related]
14. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development.
Roberts LM; Visser JA; Ingraham HA
Development; 2002 Mar; 129(6):1487-96. PubMed ID: 11880357
[TBL] [Abstract][Full Text] [Related]
15. Anti-Müllerian hormone receptor defect.
di Clemente N; Belville C
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):599-610. PubMed ID: 17161334
[TBL] [Abstract][Full Text] [Related]
16. β-Catenin is essential for Müllerian duct regression during male sexual differentiation.
Kobayashi A; Stewart CA; Wang Y; Fujioka K; Thomas NC; Jamin SP; Behringer RR
Development; 2011 May; 138(10):1967-75. PubMed ID: 21490063
[TBL] [Abstract][Full Text] [Related]
17. Welcome to the family: the anti-müllerian hormone receptor.
Grootegoed JA; Baarends WM; Themmen AP
Mol Cell Endocrinol; 1994 Apr; 100(1-2):29-34. PubMed ID: 8056154
[TBL] [Abstract][Full Text] [Related]
18. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.
Orvis GD; Jamin SP; Kwan KM; Mishina Y; Kaartinen VM; Huang S; Roberts AB; Umans L; Huylebroeck D; Zwijsen A; Wang D; Martin JF; Behringer RR
Biol Reprod; 2008 Jun; 78(6):994-1001. PubMed ID: 18322278
[TBL] [Abstract][Full Text] [Related]
19. Regulation of ovarian function: the role of anti-Müllerian hormone.
Durlinger AL; Visser JA; Themmen AP
Reproduction; 2002 Nov; 124(5):601-9. PubMed ID: 12416998
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of hormone-mediated Müllerian duct regression: involvement of beta-catenin.
Allard S; Adin P; Gouédard L; di Clemente N; Josso N; Orgebin-Crist MC; Picard JY; Xavier F
Development; 2000 Aug; 127(15):3349-60. PubMed ID: 10887090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]